UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The path to the clinic: a comprehensive review on direct KRASG12C inhibitors

Journal of experimental & clinical cancer research, 2022-01, Vol.41 (1), p.1-27, Article 27

2022

Volltextzugriff (PDF)

Panepoxydone targets NF-kB and FOXM1 to inhibit proliferation, induce apoptosis and reverse epithelial to mesenchymal transition in breast cancer

PloS one, 2014-06, Vol.9 (6), p.e98370

2014

Volltextzugriff (PDF)

Exploiting RAS Nucleotide Cycling as a Strategy for Drugging RAS-Driven Cancers

International journal of molecular sciences, 2019-12, Vol.21 (1), p.141

2019

Volltextzugriff (PDF)

Pharmacological inhibition of ABCC3 slows tumour progression in animal models of pancreatic cancer

Journal of experimental & clinical cancer research, 2019-08, Vol.38 (1), p.312-312, Article 312

2019

Volltextzugriff (PDF)

Phosphodiesterase 10A (PDE10A) as a novel target to suppress β-catenin and RAS signaling in epithelial ovarian cancer

Journal of ovarian research, 2022-11, Vol.15 (1), p.120-17, Article 120

2022

Volltextzugriff (PDF)

MicroRNA and Cancer Chemoprevention

Cancer prevention research (Philadelphia, Pa.), 2013-05, Vol.6 (5), p.401-409

2013

Volltextzugriff (PDF)

Suppression of Wnt/β-catenin signaling inhibits prostate cancer cell proliferation

European journal of pharmacology, 2009-01, Vol.602 (1), p.8-14

2009

Volltextzugriff (PDF)

Novel Non-Cyclooxygenase Inhibitory Derivative of Sulindac Inhibits Breast Cancer Cell Growth In Vitro and Reduces Mammary Tumorigenesis in Rats

Cancers, 2023-01, Vol.15 (3), p.646

2023

Volltextzugriff (PDF)

Influence of K-ras Activation on the Survival Responses of Caco-2 Cells to the Chemopreventive Agents Sulindac and Difluoromethylornithine

Cancer epidemiology, biomarkers & prevention, 2000-11, Vol.9 (11), p.1155-1162

2000

Volltextzugriff (PDF)

6-Aryl and Heterocycle Quinazoline Derivatives as Potent EGFR Inhibitors with Improved Activity toward Gefitinib-Sensitive and -Resistant Tumor Cell Lines

ChemMedChem, 2013-09, Vol.8 (9), p.1495-1504

2013

Volltextzugriff (PDF)

Sulindac sulfone inhibits azoxymethane-induced colon carcinogenesis in rats without reducing prostaglandin levels

Cancer research (Chicago, Ill.), 1997-07, Vol.57 (14), p.2909-2915

1997

Volltextzugriff (PDF)

Sulfone metabolite of sulindac inhibits mammary carcinogenesis

Cancer research (Chicago, Ill.), 1997-01, Vol.57 (2), p.267-271

1997

Volltextzugriff (PDF)

Exisulind, a novel proapoptotic drug, inhibits rat urinary bladder tumorigenesis

Cancer research (Chicago, Ill.), 2001-05, Vol.61 (10), p.3961-3968

2001

Volltextzugriff (PDF)

Phosphodiesterase 10A: a novel target for selective inhibition of colon tumor cell growth and β-catenin-dependent TCF transcriptional activity

Oncogene, 2015-03, Vol.34 (12), p.1499-1509

2015

Volltextzugriff (PDF)

Sulindac inhibits tumor cell invasion by suppressing NF-κB-mediated transcription of microRNAs

Oncogene, 2012-11, Vol.31 (48), p.4979-4986

2012

Volltextzugriff (PDF)

Inhibition of mammary carcinogenesis in rats by sulfone metabolite of sulindac

JNCI : Journal of the National Cancer Institute, 1995-08, Vol.87 (16), p.1259-1260

1995

Volltextzugriff (PDF)

Inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced mouse lung tumor formation by FGN-1 (sulindac sulfone)

Carcinogenesis (New York), 1998-08, Vol.19 (8), p.1353-1356

1998

Volltextzugriff (PDF)

Nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 selective inhibitors for prostate cancer chemoprevention. Discussion

The Journal of urology, 2004, Vol.171 (2), p.S59-S63

2004

Volltextzugriff (PDF)

207 The spatially-resolved proteomic atlas of the tumor immune architecture of HER2-positive breast cancer and response to neoadjuvant anti-HER2 therapy-based chemotherapy

Journal for immunotherapy of cancer, 2023-11, Vol.11 (Suppl 1), p.A235-A235

2023

Volltextzugriff (PDF)

Phosphodiesterase 10A: a novel target for selective inhibition of colon tumor cell growth and [beta]-catenin-dependent TCF transcriptional activity

Oncogene, 2015-03, Vol.34 (12), p.1499

2015

Volltextzugriff (PDF)

Sulindac inhibits tumor cell invasion by suppressing NF-[kappa]B-mediated transcription of microRNAs

Oncogene, 2012-11, Vol.31 (48), p.4979

2012

Volltextzugriff (PDF)

Inflammation as a Target for Prostate Cancer Chemoprevention: Pathological and Laboratory Rationale

The Journal of urology, 2004-02, Vol.171 (2), p.S30-S35

2004

Volltextzugriff (PDF)

Combinatorial Chemoprevention: Efficacy of Lovostatin and Exisulind on the Formation and Progression of Aberrant Crypt Foci

Anticancer research, 2004-05, Vol.24 (3A), p.1805-1811

2004

Volltextzugriff (PDF)

Prostate cancer chemoprevention: An overview of united states trials. Discussion

The Journal of urology, 2004, Vol.171 (2), p.S5-S9

2004

Volltextzugriff (PDF)

1 – 25 von 25

Suche als RSS-Feed

Aktive Filter

ThemaTumors

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(25)
Mit Volltextzugriff
(21)

Publikationsform

Artikel
(23)
Tagungsberichte
(2)

Sprache

Englisch
(25)

Erscheinungsjahr

n.n

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The path to the clinic: a comprehensive review on direct KRASG12C inhibitors

Panepoxydone targets NF-kB and FOXM1 to inhibit proliferation, induce apoptosis and reverse epithelial to mesenchymal transition in breast cancer

Exploiting RAS Nucleotide Cycling as a Strategy for Drugging RAS-Driven Cancers

Pharmacological inhibition of ABCC3 slows tumour progression in animal models of pancreatic cancer

Phosphodiesterase 10A (PDE10A) as a novel target to suppress β-catenin and RAS signaling in epithelial ovarian cancer

MicroRNA and Cancer Chemoprevention

Suppression of Wnt/β-catenin signaling inhibits prostate cancer cell proliferation

Novel Non-Cyclooxygenase Inhibitory Derivative of Sulindac Inhibits Breast Cancer Cell Growth In Vitro and Reduces Mammary Tumorigenesis in Rats

Influence of K-ras Activation on the Survival Responses of Caco-2 Cells to the Chemopreventive Agents Sulindac and Difluoromethylornithine

6-Aryl and Heterocycle Quinazoline Derivatives as Potent EGFR Inhibitors with Improved Activity toward Gefitinib-Sensitive and -Resistant Tumor Cell Lines

Sulindac sulfone inhibits azoxymethane-induced colon carcinogenesis in rats without reducing prostaglandin levels

Sulfone metabolite of sulindac inhibits mammary carcinogenesis

Exisulind, a novel proapoptotic drug, inhibits rat urinary bladder tumorigenesis

Phosphodiesterase 10A: a novel target for selective inhibition of colon tumor cell growth and β-catenin-dependent TCF transcriptional activity

Sulindac inhibits tumor cell invasion by suppressing NF-κB-mediated transcription of microRNAs

Inhibition of mammary carcinogenesis in rats by sulfone metabolite of sulindac

Inhibition of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone-induced mouse lung tumor formation by FGN-1 (sulindac sulfone)

Nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 selective inhibitors for prostate cancer chemoprevention. Discussion

High-plex imaging of RNA and proteins at subcellular resolution in fixed tissue by spatial molecular imaging

207 The spatially-resolved proteomic atlas of the tumor immune architecture of HER2-positive breast cancer and response to neoadjuvant anti-HER2 therapy-based chemotherapy

Phosphodiesterase 10A: a novel target for selective inhibition of colon tumor cell growth and [beta]-catenin-dependent TCF transcriptional activity

Sulindac inhibits tumor cell invasion by suppressing NF-[kappa]B-mediated transcription of microRNAs

Inflammation as a Target for Prostate Cancer Chemoprevention: Pathological and Laboratory Rationale

Combinatorial Chemoprevention: Efficacy of Lovostatin and Exisulind on the Formation and Progression of Aberrant Crypt Foci

Prostate cancer chemoprevention: An overview of united states trials. Discussion

Aktive Filter

Suchergebnisse filtern